• Future Tech Ventures invested in ProteoGuide, a Groningen-based biotech startup developing blood-based diagnostic tests from biomarker discoveries.
• ProteoGuide uses mass spectrometry to measure about 7,500 proteins from a single drop of blood to identify disease-linked biomarkers.
• Funding targets initial analyses, team build-out, hiring a project manager, execution of up to 15 studies over the next year.
• Strategy aims to advance selected programs into certified diagnostic kits for international clinical use.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Future Tech Ventures published the original content used to generate this news brief on September 28, 2026, and is solely responsible for the information contained therein.